annual cash & cash equivalents:
$217.37M-$45.62M(-17.35%)Summary
- As of today (May 29, 2025), EXEL annual cash & cash equivalents is $217.37 million, with the most recent change of -$45.62 million (-17.35%) on December 1, 2024.
- During the last 3 years, EXEL annual cash & cash equivalents has fallen by -$429.80 million (-66.41%).
- EXEL annual cash & cash equivalents is now -66.41% below its all-time high of $647.17 million, reached on December 31, 2021.
Performance
EXEL Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$183.75M-$33.62M(-15.47%)Summary
- As of today (May 29, 2025), EXEL quarterly cash & cash equivalents is $183.75 million, with the most recent change of -$33.62 million (-15.47%) on March 1, 2025.
- Over the past year, EXEL quarterly cash & cash equivalents has dropped by -$75.81 million (-29.21%).
- EXEL quarterly cash & cash equivalents is now -74.59% below its all-time high of $723.27 million, reached on March 1, 2022.
Performance
EXEL quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
EXEL Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.4% | -29.2% |
| 3 y3 years | -66.4% | -74.6% |
| 5 y5 years | -18.4% | -48.6% |
EXEL Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -66.4% | at low | -74.6% | at low |
| 5 y | 5-year | -66.4% | at low | -74.6% | at low |
| alltime | all time | -66.4% | +3925.4% | -74.6% | +3072.0% |
EXEL Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $183.75M(-15.5%) |
| Dec 2024 | $217.37M(-17.3%) | $217.37M(-15.9%) |
| Sep 2024 | - | $258.35M(+30.2%) |
| Jun 2024 | - | $198.46M(-23.5%) |
| Mar 2024 | - | $259.56M(-1.3%) |
| Dec 2023 | $262.99M(-47.5%) | $262.99M(-33.7%) |
| Sep 2023 | - | $396.86M(-14.6%) |
| Jun 2023 | - | $464.48M(-14.1%) |
| Mar 2023 | - | $540.60M(+7.9%) |
| Dec 2022 | $501.19M(-22.6%) | $501.19M(-25.8%) |
| Sep 2022 | - | $675.29M(+7.7%) |
| Jun 2022 | - | $627.00M(-13.3%) |
| Mar 2022 | - | $723.27M(+11.8%) |
| Dec 2021 | $647.17M(+102.7%) | $647.17M(+14.1%) |
| Sep 2021 | - | $567.33M(+15.2%) |
| Jun 2021 | - | $492.46M(+33.0%) |
| Mar 2021 | - | $370.21M(+16.0%) |
| Dec 2020 | $319.22M(+19.8%) | $319.22M(-4.4%) |
| Sep 2020 | - | $334.05M(-36.6%) |
| Jun 2020 | - | $527.14M(+47.5%) |
| Mar 2020 | - | $357.34M(+34.1%) |
| Dec 2019 | $266.50M(-15.3%) | $266.50M(+10.0%) |
| Sep 2019 | - | $242.32M(-34.5%) |
| Jun 2019 | - | $369.79M(-1.1%) |
| Mar 2019 | - | $373.94M(+18.8%) |
| Dec 2018 | $314.77M(+71.9%) | $314.77M(-11.0%) |
| Sep 2018 | - | $353.62M(+42.4%) |
| Jun 2018 | - | $248.41M(+6.9%) |
| Mar 2018 | - | $232.33M(+26.8%) |
| Dec 2017 | $183.16M(+20.8%) | $183.16M(+22.6%) |
| Sep 2017 | - | $149.36M(+10.5%) |
| Jun 2017 | - | $135.21M(-26.2%) |
| Mar 2017 | - | $183.18M(+20.8%) |
| Dec 2016 | $151.69M(+7.1%) | $151.69M(+36.4%) |
| Sep 2016 | - | $111.22M(-14.3%) |
| Jun 2016 | - | $129.83M(-53.1%) |
| Mar 2016 | - | $276.88M(+95.5%) |
| Dec 2015 | $141.63M(+76.2%) | $141.63M(-2.8%) |
| Sep 2015 | - | $145.64M(+135.1%) |
| Jun 2015 | - | $61.95M(-27.1%) |
| Mar 2015 | - | $84.99M(+5.7%) |
| Dec 2014 | $80.39M(-22.7%) | $80.39M(-19.7%) |
| Sep 2014 | - | $100.06M(-32.1%) |
| Jun 2014 | - | $147.34M(-6.5%) |
| Mar 2014 | - | $157.54M(+51.5%) |
| Dec 2013 | $103.98M(-38.9%) | $103.98M(+13.0%) |
| Sep 2013 | - | $92.02M(-30.2%) |
| Jun 2013 | - | $131.77M(-23.0%) |
| Mar 2013 | - | $171.23M(+0.7%) |
| Dec 2012 | $170.07M | $170.07M(-44.9%) |
| Sep 2012 | - | $308.81M(+353.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $68.14M(-3.3%) |
| Mar 2012 | - | $70.47M(-5.1%) |
| Dec 2011 | $74.26M(-23.8%) | $74.26M(+12.2%) |
| Sep 2011 | - | $66.21M(-12.0%) |
| Jun 2011 | - | $75.28M(-62.7%) |
| Mar 2011 | - | $202.05M(+107.4%) |
| Dec 2010 | $97.44M(+12.3%) | $97.44M(+2.2%) |
| Sep 2010 | - | $95.34M(-39.4%) |
| Jun 2010 | - | $157.20M(+169.7%) |
| Mar 2010 | - | $58.29M(-32.8%) |
| Dec 2009 | $86.80M(-65.0%) | $86.80M(-49.1%) |
| Sep 2009 | - | $170.57M(+11.5%) |
| Jun 2009 | - | $152.91M(-24.1%) |
| Mar 2009 | - | $201.43M(-18.7%) |
| Dec 2008 | $247.70M(+82.9%) | $247.70M(+285.6%) |
| Sep 2008 | - | $64.23M(-14.4%) |
| Jun 2008 | - | $75.05M(-38.4%) |
| Mar 2008 | - | $121.88M(-10.0%) |
| Dec 2007 | $135.46M(+9.8%) | $135.46M(-4.2%) |
| Sep 2007 | - | $141.33M(+33.8%) |
| Jun 2007 | - | $105.61M(-26.6%) |
| Mar 2007 | - | $143.84M(+16.6%) |
| Dec 2006 | $123.37M(+51.7%) | $123.37M(+121.5%) |
| Sep 2006 | - | $55.70M(-35.2%) |
| Jun 2006 | - | $86.02M(-38.6%) |
| Mar 2006 | - | $140.10M(+72.3%) |
| Dec 2005 | $81.33M(+4.1%) | $81.33M(-9.6%) |
| Sep 2005 | - | $90.01M(-14.1%) |
| Jun 2005 | - | $104.82M(+70.8%) |
| Mar 2005 | - | $61.38M(-21.4%) |
| Dec 2004 | $78.11M(-30.2%) | $78.11M(+62.7%) |
| Sep 2004 | - | $47.99M(+23.3%) |
| Jun 2004 | - | $38.92M(-51.5%) |
| Mar 2004 | - | $80.32M(-28.2%) |
| Dec 2003 | $111.83M(+23.9%) | $111.83M(+103.1%) |
| Sep 2003 | - | $55.06M(-19.7%) |
| Jun 2003 | - | $68.57M(-6.3%) |
| Mar 2003 | - | $73.15M(-19.0%) |
| Dec 2002 | $90.28M(+153.7%) | $90.28M(+207.8%) |
| Sep 2002 | - | $29.34M(+406.4%) |
| Jun 2002 | - | $5.79M(-73.0%) |
| Mar 2002 | - | $21.44M(-39.7%) |
| Dec 2001 | $35.58M(+82.0%) | $35.58M(-16.9%) |
| Sep 2001 | - | $42.81M(-7.1%) |
| Jun 2001 | - | $46.06M(+17.8%) |
| Mar 2001 | - | $39.11M(+100.1%) |
| Dec 2000 | $19.55M(+262.1%) | $19.55M(-50.3%) |
| Sep 2000 | - | $39.32M(-23.5%) |
| Jun 2000 | - | $51.42M(+328.4%) |
| Mar 2000 | - | $12.00M |
| Dec 1999 | $5.40M | - |
FAQ
- What is Exelixis annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Exelixis?
- What is Exelixis annual cash & cash equivalents year-on-year change?
- What is Exelixis quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Exelixis?
- What is Exelixis quarterly cash & cash equivalents year-on-year change?
What is Exelixis annual cash & cash equivalents?
The current annual cash & cash equivalents of EXEL is $217.37M
What is the all time high annual cash & cash equivalents for Exelixis?
Exelixis all-time high annual cash & cash equivalents is $647.17M
What is Exelixis annual cash & cash equivalents year-on-year change?
Over the past year, EXEL annual cash & cash equivalents has changed by -$45.62M (-17.35%)
What is Exelixis quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of EXEL is $183.75M
What is the all time high quarterly cash & cash equivalents for Exelixis?
Exelixis all-time high quarterly cash & cash equivalents is $723.27M
What is Exelixis quarterly cash & cash equivalents year-on-year change?
Over the past year, EXEL quarterly cash & cash equivalents has changed by -$75.81M (-29.21%)